Raymond James Financial Inc. Purchases Shares of 64,464 ICU Medical, Inc. (NASDAQ:ICUI)

Raymond James Financial Inc. purchased a new stake in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 64,464 shares of the medical instruments supplier's stock, valued at approximately $10,003,000. Raymond James Financial Inc. owned approximately 0.26% of ICU Medical as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also added to or reduced their stakes in the company. Arizona State Retirement System boosted its position in shares of ICU Medical by 1.0% during the fourth quarter. Arizona State Retirement System now owns 6,730 shares of the medical instruments supplier's stock valued at $1,044,000 after buying an additional 65 shares during the last quarter. Proficio Capital Partners LLC purchased a new position in ICU Medical during the 4th quarter worth $5,779,000. Charles Schwab Investment Management Inc. grew its stake in shares of ICU Medical by 1.0% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 304,155 shares of the medical instruments supplier's stock worth $47,196,000 after acquiring an additional 3,048 shares in the last quarter. Smartleaf Asset Management LLC raised its holdings in shares of ICU Medical by 166.8% in the fourth quarter. Smartleaf Asset Management LLC now owns 907 shares of the medical instruments supplier's stock valued at $140,000 after purchasing an additional 567 shares during the last quarter. Finally, US Bancorp DE lifted its position in shares of ICU Medical by 9.0% during the fourth quarter. US Bancorp DE now owns 3,832 shares of the medical instruments supplier's stock valued at $595,000 after purchasing an additional 315 shares in the last quarter. Institutional investors and hedge funds own 96.10% of the company's stock.

Remove Ads

ICU Medical Stock Performance

Shares of ICUI stock traded up $0.06 during trading hours on Tuesday, hitting $149.88. 238,235 shares of the company were exchanged, compared to its average volume of 256,461. ICU Medical, Inc. has a 52-week low of $93.36 and a 52-week high of $196.26. The company has a current ratio of 2.29, a quick ratio of 1.03 and a debt-to-equity ratio of 0.75. The firm has a fifty day simple moving average of $155.91 and a 200 day simple moving average of $164.35. The stock has a market capitalization of $3.67 billion, a price-to-earnings ratio of -32.80 and a beta of 0.73.

Insider Transactions at ICU Medical

In related news, CEO Vivek Jain sold 1,373 shares of the firm's stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $155.48, for a total value of $213,474.04. Following the completion of the transaction, the chief executive officer now directly owns 104,593 shares of the company's stock, valued at approximately $16,262,119.64. This trade represents a 1.30 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 6.70% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several equities research analysts have commented on ICUI shares. StockNews.com upgraded shares of ICU Medical from a "hold" rating to a "buy" rating in a research note on Tuesday, March 18th. Jefferies Financial Group upgraded ICU Medical from a "hold" rating to a "buy" rating and set a $200.00 price target on the stock in a report on Wednesday, December 11th. Finally, Raymond James set a $97.00 price objective on ICU Medical in a research note on Wednesday, March 12th. One research analyst has rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, ICU Medical presently has a consensus rating of "Buy" and a consensus target price of $168.67.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.